Sent on behalf of Marie-Claire Demblon, Head of Unit, Primary Care Group
As previously communicated, including in the 20 January 2022 primary care bulletin, practices will no longer be able to submit claims to the NHS BSA for reimbursement of locally procured PPV23 vaccines administered from April 2022 onwards, and practice’s should only be using centrally procured PPV23 vaccine for immunising their eligible population.
Arrangements are being put in place with the NHS BSA to manage any historic practice claims for locally procured PPV23 vaccine administered on or before 31 March 2022 and exceptional claims for locally procured childhood pneumococcal vaccine that is administered to an adult for clinical reasons.
As such, from the 1 April 2022:
- pneumococcal vaccines (both the PPV23 and Pneumococcal polysaccharide conjugated vaccine) will be removed from the bulk vaccine list for which claims are made via the FP34PD/D appendix form, and
- practices will be required to submit pneumococcal vaccine reimbursement claims via a prescription form (FP10) for each vaccine administered in respect of:
- PPV23 administered prior to 1 April 2022, or
- childhood pneumococcal vaccine administered to an adult for clinical reasons.
Heads of Primary Care are asked to note the above change and share the information accordingly with CCGs and practices. This information will also be communicated via the primary care bulletin, and shared with Heads of Public Health Commissioning and finance leads.